Claes Lindblad
Director of Finance/CFO at MODUS THERAPEUTICS HOLDING AB
Network origin in Claes Lindblad first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Medical Specialties | 6 | |
Public Company | Biotechnology | 4 | |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company.
2
| Private Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Claes Lindblad via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
St. Jude Medical Systems AB
St. Jude Medical Systems AB Medical SpecialtiesHealth Technology St. Jude Medical Systems AB develops, manufactures, and markets medical devices. It offers intravascular sensors to measure blood pressure in the coronary arteries for the calculation of fraction flow reserve, hemostasis management systems to stop arterial bleeding, and interventional radiology devices used in radiology interventions. The company distributes products through distributors in the United States, the United Kingdom, Germany, France, Benelux, Switzerland, Japan, Australia, and Thailand. It was founded in 1988 and is located in Uppsala, Sweden. | Medical Specialties | Chief Operating Officer | |
ABLIVA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Rosetta Capital I LP | Director/Board Member | ||
MEDIVIR AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
McGill University | College/University | Undergraduate Degree | |
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Medical Specialties | Chief Executive Officer | |
University of Linköping
University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree | |
University of Lund | College/University | Graduate Degree Doctorate Degree | |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Director/Board Member | |
Avista Capital Holdings LP
Avista Capital Holdings LP Investment ManagersFinance Avista Capital Holdings LP (Avista Capital Partners) is a private equity firm founded in 2005 by Steven Webster and Thompson Dean. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Medical Specialties | Director/Board Member | |
Heinrich-Heine-Universität Düsseldorf | College/University | Doctorate Degree | |
BONESUPPORT HOLDING AB | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
EyeSense GmbH
EyeSense GmbH Electronic Equipment/InstrumentsElectronic Technology EyeSense GmbH develops novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients. It is developing two different diagnostic systems: An ophthalmic sensor which-once inserted on the eye-can be read out optically as frequently as wanted, without any pain and a continuous sensor, to be worn on the abdomen or upper arm. The firm with its innovative sensor technology able to offer two products that addresses different needs in blood glucose monitoring which are Continuous Glucose Sensor and Eye Sensor. The company was founded in 2006 and is headquartered in Großostheim, Germany. | Electronic Equipment/Instruments | Director/Board Member | |
Grohe AS (Sweden)
Grohe AS (Sweden) Building ProductsProducer Manufacturing Grohe AS manufactures sanitary fittings and water technology products. Its products include shower heads and systems, faucet and flushing fittings, installation and water management systems for the residential, public and commercial sectors. The company is headquartered in Uppsala, Sweden. | Building Products | Director/Board Member | |
FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
Sti Technologies Ltd.
Sti Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services STI Technologies Ltd. provides marketing solutions to the health care industry. The firm's SmartTechnology platform allows stakeholders-manufacturers, pharmacies, prescribers, and payers to optimize their patient relationships. It offers solutions for pre-launch planning, brand adoption, market uptake, revenue optimization, retention and adherence, and loss of exclusivity. The company was founded by William B. Adams and Gregory Patey in 2001 and is headquartered in Halifax, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chairman | |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Merck Generics | Corporate Officer/Principal | ||
Pergamum AB
Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
INTERVACC AB | Biotechnology | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Trialbee AB
Trialbee AB Packaged SoftwareTechnology Services Trialbee AB provides software solutions and services to the pharmaceutical industry. It operates as a software company which specializes in clinical trial planning and management solutions. The firm offers global pharmaceutical companies and web-based solution for patient recruitment to clinical trials. The company was founded by Carl Johan Tobias Folkesson and Per Jonas Billing in October 2010 and is headquartered in Malmo, Sweden. | Packaged Software | Director/Board Member | |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Doctorate Degree | |
Yale School of Medicine | College/University | Doctorate Degree | |
Svenska Vaccinfabriken Produktion AB
Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Cytochrome Ltd. | Director/Board Member | ||
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | Financial Conglomerates | Corporate Officer/Principal | |
ALZECURE PHARMA AB | Biotechnology | Director/Board Member | |
Vistagen Pte Ltd. | Miscellaneous | Director/Board Member | |
Goesch Pharma Pte Ltd.
Goesch Pharma Pte Ltd. Medical DistributorsDistribution Services Goesch Pharma Pte Ltd. is a Singaporean company that wholesales pharmaceutical products. The private company is based in Singapore, Singapore. | Medical Distributors | Director/Board Member | |
GUALA CLOSURES S.P.A. | Miscellaneous Manufacturing | Director/Board Member | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Palette Life Sciences, Inc.
Palette Life Sciences, Inc. Medical SpecialtiesHealth Technology Part of Palette Life Sciences AB, Palette Life Sciences, Inc. operates as a medical device company. The private company is based in Santa Barbara, CA. The CEO of the company is Per Langoe. | Medical Specialties | Director/Board Member | |
BIOSERGEN AB | Biotechnology | Chairman | |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Swedish Orphan Biovitrum (Belgium) SARL develops treatments for diseases. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2013. Bart Fynaerts has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Tetra Holdings GmbH
Tetra Holdings GmbH Financial ConglomeratesFinance Part of Tetra Laval International SA, Tetra Holdings GmbH is a global leader in designing solutions for processing and packaging of food products. The private company is based in Hochheim am Main, Germany, and works closely with customers and suppliers to ensure food safety. Tetra Pak is a pioneer and a leading German company in food processing and packaging, with a goal to make food safe and available everywhere. Founded in 1963, the company provides insights, tips, and advice to businesses worldwide on the benefits of Tetra Pak equipment and the new opportunities they offer for operations. | Financial Conglomerates | Director/Board Member |
Statistics
International
Sweden | 24 |
United States | 11 |
United Kingdom | 6 |
Germany | 4 |
Canada | 3 |
Sectoral
Health Technology | 24 |
Finance | 9 |
Consumer Services | 7 |
Commercial Services | 4 |
Producer Manufacturing | 3 |
Operational
Director/Board Member | 94 |
Corporate Officer/Principal | 25 |
Chairman | 21 |
Chief Executive Officer | 12 |
Independent Dir/Board Member | 11 |
Most connected contacts
Insiders | |
---|---|
Viktor Drvota | 41 |
Simon Cartmell | 39 |
Torsten Rüdiger Goesch | 23 |
Newton Aguiar | 18 |
Anders Qvarnström | 12 |
John Öhd | 11 |
Per Richard Torbjörn Hallberg | 10 |
Ellen Donnelly | 6 |
Mogens Gisselbaeck | 5 |
Malin Kylberg | 3 |
Eric Patermo | 3 |
Anders Svensson | 2 |
- Stock Market
- Insiders
- Claes Lindblad
- Company connections